0001209191-19-007450.txt : 20190205
0001209191-19-007450.hdr.sgml : 20190205
20190205174812
ACCESSION NUMBER: 0001209191-19-007450
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190201
FILED AS OF DATE: 20190205
DATE AS OF CHANGE: 20190205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HELLUMS RHONDA LYNETTE
CENTRAL INDEX KEY: 0001766456
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35952
FILM NUMBER: 19569100
MAIL ADDRESS:
STREET 1: C/O ARATANA THERAPEUTICS, INC.
STREET 2: 11400 TOMAHAWK CREEK PARKWAY, SUITE 340
CITY: LEAWOOD
STATE: KS
ZIP: 66211
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARATANA THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001509190
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 383826477
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11400 TOMAHAWK CREEK PARKWAY, SUITE 340
CITY: LEAWOOD
STATE: KS
ZIP: 66211
BUSINESS PHONE: 913.353.1000
MAIL ADDRESS:
STREET 1: 11400 TOMAHAWK CREEK PARKWAY, SUITE 340
CITY: LEAWOOD
STATE: KS
ZIP: 66211
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-02-01
0
0001509190
ARATANA THERAPEUTICS, INC.
PETX
0001766456
HELLUMS RHONDA LYNETTE
C/O ARATANA THERAPEUTICS, INC.
11400 TOMAHAWK CREEK PARKWAY, SUITE 340
LEAWOOD
KS
66211
0
1
0
0
CHIEF FINANCIAL OFFICER
Common Stock
2019-02-01
4
A
0
24923
0.00
A
51424
D
Stock Option (Right to Buy)
4.44
2019-02-01
4
A
0
67527
0.00
A
2029-01-31
Common Stock
67527
67527
D
Vests as to 25% of the total number of shares (rounded down to the nearest whole share) on February 1, 2020 and as to an additional 1/48th of the total number of shares (rounded down to the nearest whole share) on the same day of each of the 36 successive calendar months thereafter, such that the stock option shall be vested as to all shares on February 1, 2023, subject to continued service with the Issuer through the applicable vesting dates.
/s/ John C. Ayres as Attorney-in-Fact for Rhonda Lynette Hellums
2019-02-05